Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laquinimod as Adjunct to GA or IFN-B in RRMS
NCT01404117Phase 2Withdrawn
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Mar 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of laquinimod in multiple sclerosis (MS), sponsored by Teva Pharmaceutical Industries Ltd.. Planned start Mar 2012; status: withdrawn.
02
Drugs
laquinimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01404117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01404117.